Document is current
Any future updates will be listed below
-
Authors
Palmgren, Victoria A. C. https://orcid.org/0000-0002-8304-0870
Cheng, Miffy Hok Yan https://orcid.org/0000-0002-0261-4642
Zhang, Yao https://orcid.org/0000-0003-2783-1317
Carlaw, Tiffany https://orcid.org/0000-0002-4144-0278
Morin, Tessa
Leung, Jerry https://orcid.org/0000-0002-8714-8440
Ross, Colin JD
Cullis, Pieter R. https://orcid.org/0000-0001-9586-2508
Molday, Robert S. https://orcid.org/0000-0002-4479-1831
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (175118, 148469)
- License Information
-
More Information
Article History
Received: 28 April 2025
Revised: 11 September 2025
Accepted: 25 November 2025
First Online: 10 December 2025
Competing interests
: PRC has financial interests in Acuitas Therapeutics, Mesentech, and NanoVation Therapeutics. The other authors declare no competing interests.
